v3.20.2
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2020
Fair Value Disclosures [Abstract]  
Fair Value, Financial Instruments Measured on Recurring Basis Our financial instruments measured at fair value on a recurring basis were as follows at the dates indicated:
Condensed Consolidated
Balance Sheet Caption
Fair Value at September 30, 2020
(in thousands) Level 1 Level 2 Level 3 Total
Liabilities:
Interest rate swap contract Other long-term liabilities $ —  $ 731  $ —  $ 731 
Contingent consideration Accrued expenses and other current liabilities —  —  —  — 
Total Liabilities $ —  $ 731  $ —  $ 731 
Condensed Consolidated
Balance Sheet Caption
Fair Value at December 31, 2019
(in thousands) Level 1 Level 2 Level 3 Total
Liabilities:
Interest rate swap contract Other long-term liabilities $ —  $ 206  $ —  $ 206 
Contingent consideration Accrued expenses and other current liabilities —  —  1,568  1,568 
Total Liabilities $ —  $ 206  $ 1,568  $ 1,774 
Schedule of Interest Rate Derivatives
Details of the outstanding swap contract as of September 30, 2020, which is a "pay-fixed and receive-floating" contract, are as follows:
Swap Maturity Notional Value
(in thousands)
Pay-Fixed Rate Receive-Floating Rate Floating Rate
Reset Terms
October 1, 2025 $ 8,170  2.07750  % One-Month LIBOR Monthly
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
A reconciliation of our liabilities that are measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3) for the nine months ended September 30, 2020 is as follows:
(in thousands) Conscious Wholesale Contingent Consideration
Balance at December 31, 2019 $ 1,568 
Foreign currency translation adjustments (14)
Payments for contingent consideration (835)
Gains from fair value adjustments included in results of operations (719)
Balance at September 30, 2020 $ —